Reduction of PTV margins for elective pelvic lymph nodes in online adaptive radiotherapy of prostate cancer patients

References

• Ekanger C, Helle SI, Heinrich D, et al. Ten-year results from a phase II study on image guided, intensity modulated radiation therapy with simultaneous integrated boost in high-risk prostate cancer. Adv Radiat Oncol. 2020;5(3):396–403. doi: 10.1016/j.adro.2019.11.007.
   PubMedGoogle Scholar
• Petersen SE, Thorsen LB, Hansen S, et al. A phase I/II study of acute and late physician assessed and patient-reported morbidity following whole pelvic radiation in high-risk prostate cancer patients. Acta Oncol. 2022;61(2):179–184. doi: 10.1080/0284186X.2021.1979246.
   PubMed Web of Science ®Google Scholar
• Murthy V, Maitre P, Kannan S, et al. Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): outcomes from phase III randomized controlled trial. J Clin Oncol. 2021;39(11):1234–1242. doi: 10.1200/JCO.20.03282.
   PubMed Web of Science ®Google Scholar
• Reis Ferreira M, Khan A, Thomas K, et al. Phase 1/2 dose-escalation study of the use of intensity modulated radiation therapy to treat the prostate and pelvic nodes in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 2017;99(5):1234–1242. doi: 10.1016/j.ijrobp.2017.07.041.
   PubMed Web of Science ®Google Scholar
• Thörnqvist S, Hysing LB, Zolnay AG, et al. Treatment simulations with a statistical deformable motion model to evaluate margins for multiple targets in radiotherapy for high-risk prostate cancer. Radiother Oncol. 2013;109(3):344–349. doi: 10.1016/j.radonc.2013.09.012.
   PubMed Web of Science ®Google Scholar
• Hewson EA, Ge Y, O'Brien R, et al. Adapting to the motion of multiple independent targets using multileaf collimator tracking for locally advanced prostate cancer: proof of principle simulation study. Med Phys. 2021;48(1):114–124. doi: 10.1002/mp.14572.
   PubMed Web of Science ®Google Scholar
• Rossi PJ, Schreibmann E, Jani AB, et al. Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer. Radiother Oncol. 2009;90(3):353–358. doi: 10.1016/j.radonc.2008.09.021.
   PubMed Web of Science ®Google Scholar
• Pilskog S, Abal B, Øvrelid KS, et al. Plan selection in proton therapy of locally advanced prostate cancer with simultaneous treatment of multiple targets. Int J Radiat Oncol Biol Phys. 2020;106(3):630–638. doi: 10.1016/j.ijrobp.2019.11.007.
   PubMed Web of Science ®Google Scholar
• Sibolt P, Andersson LM, Calmels L, et al. Clinical implementation of artificial intelligence-driven cone-beam computed tomography-guided online adaptive radiotherapy in the pelvic region. Phys Imaging Radiat Oncol. 2021;17:1–7. doi: 10.1016/j.phro.2020.12.004.
   PubMedGoogle Scholar
• Boekhoff MR, Bouwmans R, Doornaert PAH, et al. Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: an R-IDEAL stage 1b/2a evaluation of technical innovation. Clin Transl Radiat Oncol. 2022;34:82–89. doi: 10.1016/j.ctro.2022.03.008.
   PubMed Web of Science ®Google Scholar
• Budiharto T, Slagmolen P, Haustermans K, et al. Intrafractional prostate motion during online image guided intensity-modulated radiotherapy for prostate cancer. Radiother Oncol. 2011;98(2):181–186. doi: 10.1016/j.radonc.2010.12.019.
   PubMed Web of Science ®Google Scholar
• Christiansen RL, Dysager L, Hansen CR, et al. Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment. Radiother Oncol. 2022;167:165–171. doi: 10.1016/j.radonc.2021.12.013.
   PubMed Web of Science ®Google Scholar
• di Franco F, Baudier T, Gassa F, et al. Minimum non-isotropic and asymmetric margins for taking into account intrafraction prostate motion during moderately hypofractionated radiotherapy. Phys Med. 2022;96:114–120. doi: 10.1016/j.ejmp.2022.03.006.
   PubMed Web of Science ®Google Scholar
• Sheng Y, Li T, Lee WR, et al. Exploring the margin recipe for online adaptive radiation therapy for intermediate-risk prostate cancer: an intrafractional seminal vesicles motion analysis. Int J Radiat Oncol Biol Phys. 2017;98(2):473–480. doi: 10.1016/j.ijrobp.2017.02.089.
   PubMed Web of Science ®Google Scholar
• Tetar SU, Bruynzeel AME, Verweij L, et al. Magnetic resonance imaging-guided radiotherapy for intermediate- and high-risk prostate cancer: trade-off between planning target volume margin and online plan adaption. Phys Imaging Radiat Oncol. 2022;23:92–96. doi: 10.1016/j.phro.2022.06.013.
   PubMedGoogle Scholar
• Lawton CAF, Michalski J, El-Naqa I, et al. RTOG GU radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2009;74(2):383–387. doi: 10.1016/j.ijrobp.2008.08.002.
   PubMed Web of Science ®Google Scholar
• Gay HA, Barthold HJ, O'Meara E, et al. Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas. Int J Radiat Oncol Biol Phys. 2012;83(3):e353–e362. doi: 10.1016/j.ijrobp.2012.01.023.
   PubMed Web of Science ®Google Scholar
• Moazzezi M, Rose B, Kisling K, et al. Prospects for daily online adaptive radiotherapy via ethos for prostate cancer patients without nodal involvement using unedited CBCT auto‐segmentation. J Appl Clin Med Phys. 2021;22(10):82–93. doi: 10.1002/acm2.13399.
   PubMed Web of Science ®Google Scholar
• Svestad JG, Heydari M, Mikalsen SG, et al. Surface-guided positioning eliminates the need for skin markers in radiotherapy of right sided breast cancer: a single center randomized crossover trial. Radiother Oncol. 2022;177:46–52. doi: 10.1016/j.radonc.2022.10.017.
   PubMed Web of Science ®Google Scholar
• Lawton CAF, Michalski J, El-Naqa I, et al. Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2009;74(2):377–382. doi: 10.1016/j.ijrobp.2008.08.003.
   PubMed Web of Science ®Google Scholar
• Harris VA, Staffurth J, Naismith O, et al. Consensus guidelines and contouring atlas for pelvic node delineation in prostate and pelvic node intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2015;92(4):874–883. doi: 10.1016/j.ijrobp.2015.03.021.
   PubMed Web of Science ®Google Scholar
• ICRU. Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50). Report 62. 1999.*
   Google Scholar
• Kry SF, Jones J, Childress NL. Implementation and evaluation of an end-to-end IGRT test. J Appl Clin Med Phys. 2012;13(5):3939–3953. doi: 10.1120/jacmp.v13i5.3939.
   PubMed Web of Science ®Google Scholar
• Bissonnette JP, Balter PA, Dong L, et al. Quality assurance for image-guided radiation therapy utilizing CT-based technologies: a report of the AAPM TG-179. Med Phys. 2012;39(4):1946–1963. doi: 10.1118/1.3690466.
   PubMed Web of Science ®Google Scholar
• Milan T, Grogan G, Ebert MA, et al. Evaluation of the impact of the linac MLC and gantry sag in volumetric modulated arc therapy. Med Phys. 2019;46(5):1984–1994. doi: 10.1002/mp.13491.
   PubMed Web of Science ®Google Scholar
• van Herk M, Remeijer P, Rasch C, et al. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47(4):1121–1135. doi: 10.1016/s0360-3016(00)00518-6.
   PubMed Web of Science ®Google Scholar